Table 1.
Comparison of the biochemical and echocardiographic variables in coronary slow flow patients and controls
| CSF group (n=50) | Control (n=40) | p value | |
|---|---|---|---|
| Age (year) | 48.6±12.5 | 47.8±12.5 | NS |
| Gender(male/female) | 40/10 | 23/17 | NS |
| BMI (kg/m2) | 28±3.5 | 27±3.2 | NS |
| Smoking (%) | 22 (44%) | 14 (35%) | NS |
| Hypertension (%) | 0 (0%) | 0 (0%) | NS |
| Diabetes Mellitus (%) | 3 (6%) | 3 (7.5%) | NS |
| Dyslipidaemia (%) | 19 (38%) | 6 (15%) | 0.029 |
| Triglyceride (mg/dL) | 190±122.3 | 187±94.5 | NS |
| Glucose(fasting) (mg/dL) | 102±18.6 | 103±22.01 | NS |
| Creatinine (mg/dL) | 0.8±0.19 | 0.7±0.14 | NS |
| Total cholesterol (mg/dL) | 189±48.3 | 179±32.2 | S |
| HDL-Cholesterol (mg/dL) | 41±10.4 | 51±14.1 | 0.001 |
| LDL-Cholesterol (mg/dL) | 108±31.8 | 91±24.1 | NS |
| TSH (mIU/mL) | 1.46±0.42 | 1.41±0.45 | NS |
| Haemoglobin | 14±1.9 | 13±1.5 | NS |
| Haematocrit | 42.4±5.3 | 42.2±4.5 | NS |
| Heart rate (beats/min) | 77±7.3 | 80±7.1 | NS |
| Systolic blood pressure (mm/Hg) | 120±11.7 | 119±13.5 | NS |
| Diastolic blood pressure (mm/Hg) | 73±8.9 | 74±9.6 | NS |
| LVDD (mm) | 46±2.4 | 46±1.9 | NS |
| LVSD (mm) | 30±2.7 | 29±4.8 | NS |
| LVEF (%) | 60±3.5 | 60±2.4 | NS |
| LA (mm) | 36±2.1 | 35±1.1 | NS |
| E (cm/sec) | 0.7±0.14 | 0.7±0.1 | NS |
| A (cm/sec) | 0.6±0.16 | 0.6±0.14 | NS |
| E/A | 1.1±0.3 | 1.1±0.2 | NS |
CSF: coronary slow flow; BMI; body mass index; HDL: high-density lipoprotein; LDL: low-density lipoprotein; LVDD: left ventricular diastolic diameter; LVSD: left ventricular systolic diameter; LVEF: left ventricular ejection fraction; LA: left atrium diameter; E: early diastolic peak flow velocity; A: late diastolic peak flow velocity. Data are presented as means±SD; NS: non significant (p>0.05)